Literature DB >> 23357545

Dietary essential amino acids are highly anabolic in pediatric patients with cystic fibrosis.

Mariëlle P K J Engelen1, Gulnur Com, Robert R Wolfe, Nicolaas E P Deutz.   

Abstract

BACKGROUND: Current nutritional approaches have been partially successful in Cystic Fibrosis (CF). Essential amino acids mixtures with high Leucine levels (EAA) have anabolic properties in catabolic conditions, however data in CF are lacking.
METHODS: On two days according a randomized crossover design, 15 pediatric CF patients ingested 6.7 g EAA versus mixture of total amino acids as present in whey. Whole body protein and Arginine metabolism (as EAA lack Arginine) were assessed by stable isotope methodology.
RESULTS: Protein synthesis (P<0.05) but not protein breakdown was higher after EAA and 70% higher values for net anabolism (P<0.001)were found both in patients with and without nutritional failure. Arginine turnover was lower (P<0.001) and de novo Arginine synthesis tended lower (P=0.09) after EAA. Nitric oxide synthesis was not different.
CONCLUSIONS: CF patients are highly responsive to EAA intake independent of their nutritional status. Addition of Arginine to the EAA mixture may be warranted in CF.
Copyright © 2013 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Arginine production; BMI; CF; Cystic Fibrosis; DXA; EAA; Essential amino acids; FEV(1); FFM; FM; FVC; NO; NetPS; Nitric oxide synthesis; Nutritional failure; Q Arginine to Citrulline; Q Citrulline to Arginine; Ra; SE; TAA; TTR; WbPB; WbPS; Whole body protein anabolism; balanced mixture of essential and non-essential amino acids; body mass index; cTTR; de novo Arginine production; dual-energy X-ray absorptiometry; essential amino acids; fat mass; fat-free mass; forced expiratory volume in 1s; forced vital capacity; net protein synthesis; nitric oxide; nitric oxide production; rate of appearance; standard error; tracer tracee ratio; tracer–tracee ratios of amino acids corrected for their baseline value; whole body protein breakdown; whole body protein synthesis

Mesh:

Substances:

Year:  2013        PMID: 23357545      PMCID: PMC3640686          DOI: 10.1016/j.jcf.2012.12.011

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  29 in total

1.  Nutritional status of children with cystic fibrosis measured by total body potassium as a marker of body cell mass: lack of sensitivity of anthropometric measures.

Authors:  S A McNaughton; R W Shepherd; R G Greer; G J Cleghorn; B J Thomas
Journal:  J Pediatr       Date:  2000-02       Impact factor: 4.406

Review 2.  Consensus report on nutrition for pediatric patients with cystic fibrosis.

Authors:  Drucy Borowitz; Robert D Baker; Virginia Stallings
Journal:  J Pediatr Gastroenterol Nutr       Date:  2002-09       Impact factor: 2.839

Review 3.  Regulation of muscle protein by amino acids.

Authors:  Robert R Wolfe
Journal:  J Nutr       Date:  2002-10       Impact factor: 4.798

4.  Failure of conventional strategies to improve nutritional status in malnourished adolescents and adults with cystic fibrosis.

Authors:  Daina Kalnins; Mary Corey; Lynda Ellis; Paul B Pencharz; Elizabeth Tullis; Peter R Durie
Journal:  J Pediatr       Date:  2005-09       Impact factor: 4.406

5.  Use of body mass index percentile to identify fat-free mass depletion in children with cystic fibrosis.

Authors:  Mariëlle P K J Engelen; Ruth Schroder; Karin Van der Hoorn; Nicolaas E P Deutz; Gulnur Com
Journal:  Clin Nutr       Date:  2012-05-18       Impact factor: 7.324

6.  Use of a heated superficial hand vein as an alternative site for the measurement of amino acid concentrations and for the study of glucose and alanine kinetics in man.

Authors:  N N Abumrad; D Rabin; M P Diamond; W W Lacy
Journal:  Metabolism       Date:  1981-09       Impact factor: 8.694

7.  Protein metabolism in clinically stable adult cystic fibrosis patients with abnormal glucose tolerance.

Authors:  A Moran; C Milla; R Ducret; K S Nair
Journal:  Diabetes       Date:  2001-06       Impact factor: 9.461

8.  Bone density, body composition, and inflammatory status in cystic fibrosis.

Authors:  A A Ionescu; L S Nixon; W D Evans; M D Stone; V Lewis-Jenkins; K Chatham; D J Shale
Journal:  Am J Respir Crit Care Med       Date:  2000-09       Impact factor: 21.405

9.  Reduced gains in fat and fat-free mass, and elevated leptin levels in children and adolescents with cystic fibrosis.

Authors:  M L Ahme; K K Ong; A H Thomson; D B Dunger
Journal:  Acta Paediatr       Date:  2004-09       Impact factor: 2.299

10.  Insulin-like growth factor I correlates with lean body mass in cystic fibrosis patients.

Authors:  I Sermet-Gaudelus; J C Souberbielle; I Azhar; J C Ruiz; P Magnine; V Colomb; C Le Bihan; D Folio; G Lenoir
Journal:  Arch Dis Child       Date:  2003-11       Impact factor: 3.791

View more
  16 in total

Review 1.  Personalizing protein nourishment.

Authors:  David C Dallas; Megan R Sanctuary; Yunyao Qu; Shabnam Haghighat Khajavi; Alexandria E Van Zandt; Melissa Dyandra; Steven A Frese; Daniela Barile; J Bruce German
Journal:  Crit Rev Food Sci Nutr       Date:  2017-10-13       Impact factor: 11.176

2.  The bile duct ligated rat: A relevant model to study muscle mass loss in cirrhosis.

Authors:  Cristina R Bosoi; Mariana M Oliveira; Rafael Ochoa-Sanchez; Mélanie Tremblay; Gabriella A Ten Have; Nicolaas E Deutz; Christopher F Rose; Chantal Bemeur
Journal:  Metab Brain Dis       Date:  2016-12-15       Impact factor: 3.584

3.  Major surgery diminishes systemic arginine availability and suppresses nitric oxide response to feeding in patients with early stage breast cancer.

Authors:  Mariëlle P K J Engelen; V Suzanne Klimberg; Arianna Allasia; Nicolaas E P Deutz
Journal:  Clin Nutr       Date:  2017-08-05       Impact factor: 7.324

4.  Effectiveness of essential amino acid supplementation in stimulating whole body net protein anabolism is comparable between COPD patients and healthy older adults.

Authors:  Renate Jonker; Nicolaas Ep Deutz; Marcia L Erbland; Paula J Anderson; Mariëlle Pkj Engelen
Journal:  Metabolism       Date:  2016-12-20       Impact factor: 8.694

5.  Comprehensive metabolic flux analysis to explain skeletal muscle weakness in COPD.

Authors:  Mariëlle P K J Engelen; Renate Jonker; John J Thaden; Gabriella A M Ten Have; Moon Sun Jeon; Srinivasan Dasarathy; Nicolaas E P Deutz
Journal:  Clin Nutr       Date:  2020-01-29       Impact factor: 7.324

6.  Hydrolyzed casein and whey protein meals comparably stimulate net whole-body protein synthesis in COPD patients with nutritional depletion without an additional effect of leucine co-ingestion.

Authors:  Renate Jonker; Nicolaas E P Deutz; Marcia L Erbland; Paula J Anderson; Mariëlle P K J Engelen
Journal:  Clin Nutr       Date:  2013-07-01       Impact factor: 7.324

7.  Phenylalanine isotope pulse method to measure effect of sepsis on protein breakdown and membrane transport in the pig.

Authors:  Gabriella A M Ten Have; Mariëlle P K J Engelen; Robert R Wolfe; Nicolaas E P Deutz
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-03-14       Impact factor: 4.310

Review 8.  Protein is an important but undervalued macronutrient in the nutritional care of patients with cystic fibrosis.

Authors:  Mariëlle P K J Engelen; Gulnur Com; Nicolaas E P Deutz
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2014-11       Impact factor: 4.294

9.  High anabolic potential of essential amino acid mixtures in advanced nonsmall cell lung cancer.

Authors:  M P K J Engelen; A M Safar; T Bartter; F Koeman; N E P Deutz
Journal:  Ann Oncol       Date:  2015-06-25       Impact factor: 32.976

10.  New stable isotope method to measure protein digestibility and response to pancreatic enzyme intake in cystic fibrosis.

Authors:  M P K J Engelen; G Com; P J Anderson; N E P Deutz
Journal:  Clin Nutr       Date:  2013-11-09       Impact factor: 7.324

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.